Which is a typical empiric regimen for early neonatal sepsis?

• A. Amoxicillin monotherapy.
• B. Ampicillin plus gentamicin (with or without a third-generation cephalosporin).
• C. Doxycycline.
• D. Ciprofloxacin alone.

Answer: (B)

The key idea here is choosing empiric antibiotics that cover the pathogens neonates are most at risk for in early sepsis, while staying safe for a newborn. Ampicillin targets the Gram-positive organisms most commonly involved, including group B Streptococcus and Listeria, and it also provides some coverage for Enterococcus. Gentamicin adds robust activity against Gram-negative bacteria, especially E. coli, which are frequent culprits in early-onset sepsis. Using them together gives broad initial coverage across the principal neonatal pathogens, before culture results come back. In some situations, adding a third-generation cephalosporin like cefotaxime is considered if meningitis is a concern or if the local pathogens or resistance patterns warrant broader Gram-negative coverage; that’s why the option notes it may be used “with or without” a third-generation cephalosporin.

Doxycycline and ciprofloxacin are not used as first-line empiric therapy in neonates due to safety concerns—doxycycline can affect teeth and bones, and fluoroquinolones like ciprofloxacin can impact cartilage development. Amoxicillin alone wouldn’t provide adequate Gram-negative coverage for this setting, so it isn’t the best empiric choice.